Study evaluated the effectiveness of mRNA COVID-19 vaccines (BNT162b2, mRNA-1273, and heterologous schedules) in preventing hospitalization among adolescents in Nordic countries, finding high protection rates of 73% to 86% at six months.
Researchers Challenge USPSTF’s Lung Cancer Screening Criteria
Alternative criteria for lung cancer screening identified high-benefit groups who were not covered by U.S. Preventive Services Task Force (USPSTF) criteria, according to results based
August 21, 2024